• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于脑脊液生物标志物的散发性克雅氏病诊断:对先前确定的临界值的验证研究

Cerebrospinal Fluid Biomarker-Based Diagnosis of Sporadic Creutzfeldt-Jakob Disease: A Validation Study for Previously Established Cutoffs.

作者信息

Llorens Franc, Karch André, Golanska Ewa, Schmitz Matthias, Lange Peter, Sikorska Beata, Liberski Pawel P, Zerr Inga

机构信息

Department of Neurology, University Medical Center Göttingen, and German Center for Neurodegenerative Diseases (DZNE)-site Göttingen, Göttingen, Germany.

出版信息

Dement Geriatr Cogn Disord. 2017;43(1-2):71-80. doi: 10.1159/000454802. Epub 2017 Jan 6.

DOI:10.1159/000454802
PMID:28056460
Abstract

BACKGROUND

Several biomarkers have been proposed to discriminate sporadic Creutzfeldt-Jakob disease (sCJD) from other dementias and control cases. However, their clinical accuracy depends on the PRNP codon 129 genotype, leaving it unclear how well established markers behave in untested conditions.

METHODS

We analyzed 14-3-3, tau, p-tau levels, and the p-tau/tau ratio in a population sample collected from Polish hospitals including nondementia, dementia, and definite sCJD cases and validated their parameters according to previously established cutoffs. Additionally, the correlation between biomarkers and disease duration as well as the influence of the PRNP129 polymorphism are reported.

RESULTS

The tau levels and p-tau/tau ratios differed considerably between sCJD and clinically characterized non-CJD cases (p < 0.001). p-tau was only elevated in sCJD when compared to cases without dementia (p < 0.05). Tau and the p-tau/tau ratio showed a sensitivity of 95 and 100%, respectively, in detecting sCJD cases. A negative correlation between tau levels and disease duration, but not the timing of lumbar puncture was observed.

CONCLUSION

The present findings confirmed the value of the p-tau/tau ratio as a robust sCJD biomarker and suggest a role for tau as prognostic marker.

摘要

背景

已经提出了几种生物标志物来区分散发性克雅氏病(sCJD)与其他痴呆症及对照病例。然而,它们的临床准确性取决于PRNP密码子129基因型,尚不清楚既定标志物在未经测试的情况下表现如何。

方法

我们分析了从波兰医院收集的人群样本中的14-3-3、tau、p-tau水平以及p-tau/tau比值,该样本包括非痴呆、痴呆和确诊的sCJD病例,并根据先前确定的临界值验证了它们的参数。此外,报告了生物标志物与疾病持续时间之间的相关性以及PRNP129多态性的影响。

结果

sCJD与具有临床特征的非CJD病例之间的tau水平和p-tau/tau比值存在显著差异(p < 0.001)。与无痴呆病例相比,p-tau仅在sCJD中升高(p < 0.05)。Tau和p-tau/tau比值在检测sCJD病例时的敏感性分别为95%和100%。观察到tau水平与疾病持续时间呈负相关,但与腰椎穿刺时间无关。

结论

本研究结果证实了p-tau/tau比值作为一种可靠的sCJD生物标志物的价值,并表明tau作为预后标志物的作用。

相似文献

1
Cerebrospinal Fluid Biomarker-Based Diagnosis of Sporadic Creutzfeldt-Jakob Disease: A Validation Study for Previously Established Cutoffs.基于脑脊液生物标志物的散发性克雅氏病诊断:对先前确定的临界值的验证研究
Dement Geriatr Cogn Disord. 2017;43(1-2):71-80. doi: 10.1159/000454802. Epub 2017 Jan 6.
2
CSF Tau proteins reduce misdiagnosis of sporadic Creutzfeldt-Jakob disease suspected cases with inconclusive 14-3-3 result.脑脊液 Tau 蛋白可减少 14-3-3 结果不确定的散发性克雅氏病疑似病例的误诊。
J Neurol. 2016 Sep;263(9):1847-61. doi: 10.1007/s00415-016-8209-x. Epub 2016 Jun 29.
3
Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.散发性克雅氏病中朊病毒生物标志物的亚型和区域调控
Neuropathol Appl Neurobiol. 2015 Aug;41(5):631-45. doi: 10.1111/nan.12175. Epub 2015 Apr 30.
4
Sporadic Creutzfeldt-Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay.一种新的脑脊液ELISA 14-3-3γ检测方法提高了散发性克雅氏病的诊断准确性。
Neuroscience. 2016 May 13;322:398-407. doi: 10.1016/j.neuroscience.2016.02.057. Epub 2016 Mar 3.
5
Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.脑脊液生物标志物在斯洛伐克患者克雅氏病诊断中的应用:10 年回顾性研究。
Mol Neurobiol. 2017 Oct;54(8):5919-5927. doi: 10.1007/s12035-016-0128-4. Epub 2016 Sep 24.
6
The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review.英国散发性克雅氏病中脑脊液 14-3-3 和其他蛋白的诊断作用:10 年回顾。
J Neurol Neurosurg Psychiatry. 2010 Nov;81(11):1243-8. doi: 10.1136/jnnp.2009.197962. Epub 2010 Sep 20.
7
Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.脑脊液蛋白质谱在葡萄牙散发性克雅氏病患者群体中的诊断价值。
J Neurol. 2009 Sep;256(9):1540-50. doi: 10.1007/s00415-009-5160-0. Epub 2009 May 6.
8
Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.克雅氏病中朊病毒特异性及替代脑脊液生物标志物:与分子亚型相关的诊断准确性以及p- tau和Aβ42水平的神经病理学相关性分析
Acta Neuropathol. 2017 Apr;133(4):559-578. doi: 10.1007/s00401-017-1683-0. Epub 2017 Feb 15.
9
Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt-Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia.在快速进展性痴呆的临床环境中,血浆 GFAP 在散发性克雅氏病中的诊断和预后价值。
Int J Mol Sci. 2024 May 8;25(10):5106. doi: 10.3390/ijms25105106.
10
Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease.散发性克雅氏病中的脑脊液标志物
Int J Mol Sci. 2011;12(9):6281-92. doi: 10.3390/ijms12096281. Epub 2011 Sep 23.

引用本文的文献

1
A Systematic Review of Sporadic Creutzfeldt-Jakob Disease: Pathogenesis, Diagnosis, and Therapeutic Attempts.散发性克雅氏病的系统评价:发病机制、诊断及治疗尝试
Neurol Int. 2024 Sep 20;16(5):1039-1065. doi: 10.3390/neurolint16050079.
2
Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?神经退行性疾病的病理生理学:轴突运输失败、氧化应激和炎症之间的相互作用?
Semin Immunol. 2022 Jan;59:101628. doi: 10.1016/j.smim.2022.101628. Epub 2022 Jun 30.
3
Role of Biomarkers for the Diagnosis of Prion Diseases: A Narrative Review.
用于朊病毒病诊断的生物标志物的作用:叙述性综述。
Medicina (Kaunas). 2022 Mar 25;58(4):473. doi: 10.3390/medicina58040473.
4
Total and Phosphorylated Cerebrospinal Fluid Tau in the Differential Diagnosis of Sporadic Creutzfeldt-Jakob Disease and Rapidly Progressive Alzheimer's Disease.脑脊液总 tau 和磷酸化 tau 在散发性克雅氏病和快速进展性阿尔茨海默病鉴别诊断中的应用。
Viruses. 2022 Jan 28;14(2):276. doi: 10.3390/v14020276.
5
Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease.散发性克雅氏病的生物标志物和诊断指南。
Lancet Neurol. 2021 Mar;20(3):235-246. doi: 10.1016/S1474-4422(20)30477-4.
6
Diagnostic Accuracy of Prion Disease Biomarkers in Iatrogenic Creutzfeldt-Jakob Disease.朊病毒病生物标志物在医源性克雅氏病中的诊断准确性。
Biomolecules. 2020 Feb 12;10(2):290. doi: 10.3390/biom10020290.
7
Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases.朊病毒病谱中脑脊液总朊蛋白。
Mol Neurobiol. 2019 Apr;56(4):2811-2821. doi: 10.1007/s12035-018-1251-1. Epub 2018 Jul 30.
8
CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJD.脑脊液非磷酸化 Tau 作为鉴别阿尔茨海默病与克雅氏病的生物标志物。
Ann Clin Transl Neurol. 2018 May 26;5(7):883-887. doi: 10.1002/acn3.584. eCollection 2018 Jul.
9
Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum.神经丝和磷酸化 tau/总 tau 比值在额颞叶痴呆谱中的临床价值。
Neurology. 2018 Apr 3;90(14):e1231-e1239. doi: 10.1212/WNL.0000000000005261. Epub 2018 Mar 7.
10
YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias.神经退行性痴呆症患者脑和脑脊液中的 YKL-40。
Mol Neurodegener. 2017 Nov 10;12(1):83. doi: 10.1186/s13024-017-0226-4.